Unlock the Editor’s Digest for free
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.
The Federal Trade Commission has sued America’s largest prescription-drug “gatekeepers” over a “perverse drug rebate system” that it alleges artificially raised insulin prices.
The competition regulator’s complaint names CVS Health’s Caremark, Cigna’s Express Scripts and UnitedHealth Group’s Optum, which administer about 80 per cent of all…
Read the full article here